Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge?
John Niederhuber named NCI chief operating officer; the surgeon was asked to leave two previous positions.
Cancer death rate dropping 1.1 percent a year, annual report finds.
Trending Stories
- “All in Her Head” catalogs the history of medicine’s atrocities against women
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
- Chernobyl: a 35 year follow up on long-term health effects
- Prominent GI oncologist Axel Grothey was forced out of Mayo Clinic for unethical sexual relationships with women he mentored
Three reprimands later, he retains leadership—and mentorship—positions - CMS starts paying for patient navigation; ACS offers navigation credentialing program